Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EBIT (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of EBIT data on record, last reported at $50.3 million in Q4 2025.

  • For Q4 2025, EBIT rose 97.1% year-over-year to $50.3 million; the TTM value through Dec 2025 reached $168.8 million, up 106.96%, while the annual FY2025 figure was $110.5 million, 107.19% up from the prior year.
  • EBIT reached $50.3 million in Q4 2025 per PAHC's latest filing, down from $51.3 million in the prior quarter.
  • Across five years, EBIT topped out at $51.3 million in Q3 2025 and bottomed at -$726000.0 in Q3 2023.
  • Average EBIT over 5 years is $22.8 million, with a median of $19.6 million recorded in 2022.
  • Peak YoY movement for EBIT: crashed 105.31% in 2023, then surged 2537.88% in 2024.
  • A 5-year view of EBIT shows it stood at $22.3 million in 2021, then fell by 28.93% to $15.8 million in 2022, then decreased by 0.9% to $15.7 million in 2023, then skyrocketed by 62.62% to $25.5 million in 2024, then surged by 97.1% to $50.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $50.3 million in Q4 2025, $51.3 million in Q3 2025, and $33.7 million in Q2 2025.